Brolucizumab in age-related macular neovascularization (BRAIN study): Efficacy, optical coherence tomography biomarkers, and safety profile
Background: Brolucizumab is a new anti-vascular endothelial growth factor (anti-VEGF) in the treatment of neovascular age-related macular degeneration (nAMD) and idiopathic polypoidal choroidal vasculopathy (IPCV). Materials and Methods: A retrospective, consecutive, interventional study was conduct...
| Main Authors: | , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| 丛编: | Indian Journal of Ophthalmology |
| 主题: | |
| 在线阅读: | http://www.ijo.in/article.asp?issn=0301-4738;year=2024;volume=72;issue=13;spage=33;epage=36;aulast=Dabir |